{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:19:53Z","timestamp":1790428793546,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T00:00:00Z","timestamp":1306108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020062","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T20:56:49Z","timestamp":1306184209000},"page":"e20062","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the Mouse"],"prefix":"10.1371","volume":"6","author":[{"given":"Paul C.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Kirkby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetty N.","family":"Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,5,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38195-9","article-title":"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.","volume":"289","author":"F Catella-Lawson","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.","volume":"96","author":"BF McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis.","volume":"343","author":"C Bombardier","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.","volume":"115","author":"EM Antman","year":"2007","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.","volume":"116","author":"T Grosser","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(08)60137-3","article-title":"COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs.","volume":"371","author":"TD Warner","year":"2008","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.","volume":"5","author":"JA Mitchell","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mi.9.1.8","article-title":"Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.","volume":"9","author":"C Patrono","year":"2009","journal-title":"Mol Interv"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1096\/fj.03-0645rev","article-title":"Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.","volume":"18","author":"TD Warner","year":"2004","journal-title":"Faseb J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.","volume":"332","author":"PM Kearney","year":"2006","journal-title":"Bmj"},{"key":"ref11","article-title":"Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?","author":"N Zidar","year":"2008"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tips.2007.01.003","article-title":"Balancing prostanoid activity in the human vascular system.","volume":"28","author":"NA Flavahan","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/ATVBAHA.110.214031","article-title":"Role of shear stress in endothelial cell morphology and expression of cyclooxygenase isoforms.","volume":"31","author":"CM Potter","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.0000258106.74139.25","article-title":"Cardiovascular effects of the cyclooxygenase inhibitors.","volume":"49","author":"WB White","year":"2007","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/273767a0","article-title":"Prostacyclin is a circulating hormone.","volume":"273","author":"S Moncada","year":"1978","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.","volume":"108","author":"C Patrono","year":"2001","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/jm000069h","article-title":"N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration.","volume":"43","author":"JJ Talley","year":"2000","journal-title":"J Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis.","volume":"353","author":"C Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1160\/TH07-07-0479","article-title":"Real-time measurement of non-lethal platelet thromboembolic responses in the anaesthetized mouse.","volume":"99","author":"C Tymvios","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1160\/TH09-11-0764","article-title":"Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase.","volume":"104","author":"C Moore","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2008.11.017","article-title":"Role of platelets in atherothrombosis.","volume":"103","author":"LK Jennings","year":"2009","journal-title":"Am J Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet aggregation.","volume":"109","author":"SP Jackson","year":"2007","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1538-7836.2008.03133.x","article-title":"Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2.","volume":"6","author":"PC Armstrong","year":"2008","journal-title":"J Thromb Haemost"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2002-05-1363","article-title":"The roles of alphaIIb beta3-mediated outside-in signal transduction, thromboxane A<sub>2<\/sub>, and adenosine diphosphate in collagen-induced platelet aggregation.","volume":"101","author":"MJ Cho","year":"2003","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet Activation and Atherothrombosis.","volume":"357","author":"G Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09537100601024111","article-title":"Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways.","volume":"18","author":"BB Dawood","year":"2007","journal-title":"Platelets"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2141.2000.02208.x","article-title":"The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.","volume":"110","author":"RF Storey","year":"2000","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/273765a0","article-title":"Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.","volume":"273","author":"RJ Gryglewski","year":"1978","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0090-6980(80)80010-4","article-title":"Carbacyclin\u2013a potent stable prostacyclin analogue for the inhibition of platelet aggregation.","volume":"19","author":"BJ Whittle","year":"1980","journal-title":"Prostaglandins"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/0006-2952(84)90604-X","article-title":"Regulation of human platelet activation\u2013analysis of cyclooxygenase and cyclic AMP-dependent pathways.","volume":"33","author":"S Krishnamurthi","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1073\/pnas.061607398","article-title":"Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.","volume":"98","author":"D Pratico","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0702518","article-title":"Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.","volume":"126","author":"F Giuliano","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.","volume":"96","author":"TD Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(01)01207-9","article-title":"Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation.","volume":"426","author":"F Giuliano","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1399-6576.1997.tb04657.x","article-title":"Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers.","volume":"41","author":"TT Niemi","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0609.1984.tb02390.x","article-title":"Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans.","volume":"33","author":"S Cronberg","year":"1984","journal-title":"Scand J Haematol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:34:32Z","timestamp":1741203272000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020062"}},"subtitle":[],"editor":[{"given":"Harald H. H. W.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,5,23]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020062","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,23]]}}}